Literature DB >> 1968796

Cloning and nucleotide sequence of cDNA for Ki antigen, a highly conserved nuclear protein detected with sera from patients with systemic lupus erythematosus.

T Nikaido1, K Shimada, M Shibata, M Hata, M Sakamoto, Y Takasaki, C Sato, T Takahashi, Y Nishida.   

Abstract

Patients with systemic lupus erythematosus (SLE) produce autoantibodies against a variety of nuclear antigens including Ki antigen. Although anti-Ki autoantibodies were found in a significant number of SLE patients, the nature of Ki antigen is poorly characterized. By using anti-Ki serum as a probe we have cloned a bovine cDNA directing the synthesis in Escherichia coli of a polypeptide immunologically indistinguishable from the authentic Ki antigen. A homologous human cDNA was also cloned and its nucleotide sequence predicted the entire primary structure of a novel nuclear protein with a molecular weight of 29 508 and with highly hydrophilic and weakly acidic character. The gene is highly conserved not only in the coding region but also in the 3'-untranslated region. The bacterially produced Ki antigen would be valuable for diagnosis of SLE.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1968796      PMCID: PMC1534747          DOI: 10.1111/j.1365-2249.1990.tb05180.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  A short amino acid sequence able to specify nuclear location.

Authors:  D Kalderon; B L Roberts; W D Richardson; A E Smith
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

2.  Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing.

Authors:  S Henikoff
Journal:  Gene       Date:  1984-06       Impact factor: 3.688

3.  Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  1984-01-25       Impact factor: 16.971

4.  Precipitating antibody to a soluble nuclear antigen "Ki" with specificity for systemic lupus erythematosus.

Authors:  T Tojo; J Kaburaki; M Hayakawa; T Okamoto; M Tomii; M Homma
Journal:  Ryumachi       Date:  1981

5.  Characterization of a Mr = 56,000 polypeptide associated with 10S DNA polymerase alpha purified from calf thymus using monoclonal antibody.

Authors:  S Masaki; K Tamai; R Suzuki; K Tanabe; T Takahashi; S Yoshida
Journal:  Nucleic Acids Res       Date:  1985-09-25       Impact factor: 16.971

6.  Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus.

Authors:  M R Lerner; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

7.  Identity of the proliferating cell nuclear antigen and cyclin.

Authors:  M B Mathews; R M Bernstein; B R Franza; J I Garrels
Journal:  Nature       Date:  1984 May 24-30       Impact factor: 49.962

8.  Human anticentromere antibodies: distribution, characterization of antigens, and effect on microtubule organization.

Authors:  J V Cox; E A Schenk; J B Olmsted
Journal:  Cell       Date:  1983-11       Impact factor: 41.582

9.  Primary structure of the alpha-subunit of transducin and its relationship to ras proteins.

Authors:  T Tanabe; T Nukada; Y Nishikawa; K Sugimoto; H Suzuki; H Takahashi; M Noda; T Haga; A Ichiyama; K Kangawa
Journal:  Nature       Date:  1985 May 16-22       Impact factor: 49.962

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  17 in total

1.  Subcellular localization of proteasomes and their regulatory complexes in mammalian cells.

Authors:  P Brooks; G Fuertes; R Z Murray; S Bose; E Knecht; M C Rechsteiner; K B Hendil; K Tanaka; J Dyson; J Rivett
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

2.  Lysine 188 substitutions convert the pattern of proteasome activation by REGgamma to that of REGs alpha and beta.

Authors:  J Li; X Gao; J Ortega; T Nazif; L Joss; M Bogyo; A C Steven; M Rechsteiner
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

Review 3.  Structural and functional properties of proteasome activator PA28.

Authors:  L Kuehn; B Dahlmann
Journal:  Mol Biol Rep       Date:  1997-03       Impact factor: 2.316

Review 4.  Origin and evolution of the specialized forms of proteasomes involved in antigen presentation.

Authors:  Masanori Kasahara; Martin F Flajnik
Journal:  Immunogenetics       Date:  2019-01-24       Impact factor: 2.846

Review 5.  Peptide splicing by the proteasome.

Authors:  Nathalie Vigneron; Violette Ferrari; Vincent Stroobant; Joanna Abi Habib; Benoit J Van den Eynde
Journal:  J Biol Chem       Date:  2017-11-06       Impact factor: 5.157

6.  High expression of REGγ is associated with metastasis and poor prognosis of patients with breast cancer.

Authors:  Fan Chai; Yan Liang; Jiong Bi; Li Chen; Fan Zhang; Youhong Cui; Xiuwu Bian; Jun Jiang
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

Review 7.  The proteasome activator 11 S REG (PA28) and class I antigen presentation.

Authors:  M Rechsteiner; C Realini; V Ustrell
Journal:  Biochem J       Date:  2000-01-01       Impact factor: 3.857

8.  A differential screen for ligand-regulated genes: identification of HoxA10 as a target of vitamin D3 induction in myeloid leukemic cells.

Authors:  N Y Rots; M Liu; E C Anderson; L P Freedman
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

9.  Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein.

Authors:  Kohji Moriishi; Tamaki Okabayashi; Kousuke Nakai; Kyoji Moriya; Kazuhiko Koike; Shigeo Murata; Tomoki Chiba; Keiji Tanaka; Ryosuke Suzuki; Tetsuro Suzuki; Tatsuo Miyamura; Yoshiharu Matsuura
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Analysis of the gene expression profile of Schistosoma japonicum cercariae by a strategy based on expressed sequence tags.

Authors:  Hong-Juan Peng; Xiao-Guang Chen; Xun-Zhang Wang; Zhao-Rong Lun
Journal:  Parasitol Res       Date:  2003-03-26       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.